Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Herbert, Andrew S."" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
Autorzy:
Voss WN; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Johnson NV; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Delidakis G; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Kim JE; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
Javanmardi K; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Horton AP; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Bartzoka F; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Paresi CJ; Department of Chemistry, The University of Texas at Austin, Austin, TX, USA.
Tanno Y; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Chou CW; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Abbasi SA; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
Pickens W; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
George K; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Boutz DR; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.; CCDC Army Research Laboratory-South, The University of Texas at Austin, Austin, TX, USA.
Towers DM; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
McDaniel JR; Biomedicine Design, Pfizer, Cambridge, MA, USA.
Billick D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Goike J; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Rowe L; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Tulane National Primate Research Center Department of Microbiology 18703 Three Rivers Road Covington, LA, USA.
Batra D; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pohl J; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lee J; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Gangappa S; Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sambhara S; Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Gadush M; Center for Biomedical Research Support, The University of Texas at Austin, Austin, TX, USA.
Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Person MD; Center for Biomedical Research Support, The University of Texas at Austin, Austin, TX, USA.
Iverson BL; Department of Chemistry, The University of Texas at Austin, Austin, TX, USA.
Gollihar JD; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.; CCDC Army Research Laboratory-South, The University of Texas at Austin, Austin, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.
Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
Finkelstein IJ; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Georgiou G; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.; Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
Lavinder JJ; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA. .; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Ippolito GC; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA. .; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.; Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2021 Jun 04; Vol. 372 (6546), pp. 1108-1112. Date of Electronic Publication: 2021 May 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
COVID-19/*immunology
Immunoglobulin G/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Animals ; Antibodies, Monoclonal/blood ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/chemistry ; Antibodies, Viral/blood ; Antibodies, Viral/chemistry ; Antibody Affinity ; COVID-19/prevention & control ; Epitopes/immunology ; Humans ; Immune Evasion ; Immunoglobulin G/blood ; Immunoglobulin G/chemistry ; Immunoglobulin Heavy Chains/immunology ; Immunoglobulin Variable Region/immunology ; Mice ; Mice, Inbred BALB C ; Mutation ; Protein Domains ; Proteomics ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/genetics
Czasopismo naukowe
Tytuł:
Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
Autorzy:
Jae LT; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Raaben M; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA.
Kuehne AI; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA.
Wirchnianski AS; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA.
Soh TK; Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Stubbs SH; Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Janssen H; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Damme M; Biochemisches Institut, Christian Albrechts-Universität Kiel, 24118 Kiel, Germany.
Saftig P; Biochemisches Institut, Christian Albrechts-Universität Kiel, 24118 Kiel, Germany.
Whelan SP; Department of Microbiology and Immunobiology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. _.
Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA. _.
Brummelkamp TR; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria. Cancer Genomics Center (CGC.nl), Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. _.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2014 Jun 27; Vol. 344 (6191), pp. 1506-10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Virus Internalization*
Lassa virus/*physiology
Lysosomal-Associated Membrane Protein 1/*metabolism
Receptors, Virus/*metabolism
Viral Envelope Proteins/*metabolism
Amino Acid Sequence ; Animals ; Cell Line ; Cell Membrane/metabolism ; Cell Membrane/virology ; Cells, Cultured ; Chickens ; Dystroglycans/genetics ; Dystroglycans/metabolism ; Glycosylation ; Humans ; Hydrogen-Ion Concentration ; Lassa Fever/virology ; Lysosomal-Associated Membrane Protein 1/chemistry ; Lysosomes/metabolism ; Lysosomes/virology ; Mice ; Mice, Knockout ; Molecular Sequence Data ; Protein Binding ; Sialyltransferases/metabolism ; beta-Galactoside alpha-2,3-Sialyltransferase
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies